AU
UK
CA
NZ
IND
US
Shares in Ensysce Biosciences (Nasdaq: ENSC) closed 9 per cent higher at $0.38 on Tuesday, as the company placed itself at the centre of one of the most consequential debates in contemporary pharmacology: how to engineer effective pain relief without handing patients or recreational …
Introduction
The Return Nobody Expected
A Structural Contest, Not a Crisis
From Oil Markets to Farm Fields: How the Iran Conflict Is ReshapingCommodityPositioning
TheBond Market's verdict
A Thin Shield Against a Structural Problem
A Market That Appears Whole But Is Not
Key Highlights
Please wait processing your request...